Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 1
2017 3
2018 4
2019 1
2020 1
2021 2
2022 11
2023 4
2024 6
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tokuyama H, Sakamoto H, Fujita T, Nanasato M, Okayama H, Nishikura T, Kirigaya H, Nishida K, Ono K, Kimura T; STOPDAPT-3 investigators. Obayashi Y, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Aug 14;10(5):374-390. doi: 10.1093/ehjcvp/pvae009. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38285607 Clinical Trial.
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Akao M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T; STOPDAPT-3 Investigators. Yamamoto K, et al. JACC Cardiovasc Interv. 2024 May 13;17(9):1119-1130. doi: 10.1016/j.jcin.2024.03.017. JACC Cardiovasc Interv. 2024. PMID: 38749592 Free article.
An Aspirin-Free Strategy for Patients Undergoing Staged Percutaneous Coronary Intervention　- A Subgroup Analysis of the STOPDAPT-3 Trial.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Yokomatsu T, Chinen T, Doijiri T, Kozuma K, Nishida Y, Yamaguchi K, Kitahara H, Ishino M, Ono K, Kimura T; STOPDAPT-3 Investigators. Yamamoto K, et al. Among authors: doijiri t. Circ Rep. 2025 Apr 29;7(6):451-462. doi: 10.1253/circrep.CR-25-0026. eCollection 2025 Jun 10. Circ Rep. 2025. PMID: 40497118 Free PMC article.
Prognostic Impact of Renal Function on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization.
Itakura R, Kuramitsu S, Kikuchi J, Kawase Y, Mizukami T, Shinozaki T, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Yokoi H, Tanaka N, Matsuo H; J‐CONFIRM investigators. Itakura R, et al. Among authors: doijiri t. J Am Heart Assoc. 2023 Oct 17;12(20):e030886. doi: 10.1161/JAHA.123.030886. Epub 2023 Oct 7. J Am Heart Assoc. 2023. PMID: 37804198 Free PMC article.
Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularization.
Ishii M, Kuramitsu S, Yamanaga K, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Kanemura N, Sonoda S, Yokoi H, Tanaka N, Tsujita K; J- CONFIRM Registry Investigators. Ishii M, et al. Among authors: doijiri t. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 3;8(6):600-608. doi: 10.1093/ehjcvp/pvac008. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35108383
Thrombotic Risk and Cardiovascular Events in Patients With Revascularization Deferral After Fractional Flow Reserve Assessment.
Shiono Y, Kuramitsu S, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Asano T, Tsujita K, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Tanaka A, Yokoi H, Tanaka N; J-CONFIRM Registry Investigators. Shiono Y, et al. Among authors: doijiri t. JACC Cardiovasc Interv. 2022 Feb 28;15(4):427-439. doi: 10.1016/j.jcin.2021.11.020. JACC Cardiovasc Interv. 2022. PMID: 35210049 Free article.
Five-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Infarct-Related Artery Lesions.
Ohashi H, Kuramitsu S, Takashima H, Matsuo H, Horie K, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Tsujita K, Masamura K, Doijiri T, Sasaki Y, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Sonoda S, Amano T, Yokoi H, Tanaka N; J-CONFIRM Investigators. Ohashi H, et al. Among authors: doijiri t. J Soc Cardiovasc Angiogr Interv. 2023 May 2;2(3):100632. doi: 10.1016/j.jscai.2023.100632. eCollection 2023 May-Jun. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39130706 Free PMC article.
31 results